Search

everythinglearnresearchcommunity

for

Search:↓

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

AGA patients have higher heart disease risk.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Disrupting natural body clocks increases the risk of developing type 2 diabetes.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Young women with PCOS and no other heart risk factors have normal heart function.

The free androgen index varies among women with different types of PCOS.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Insulin resistance linked to obesity may increase COVID-19 severity.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Women with PCOS often have more belly fat and higher insulin levels, but belly fat isn't the only cause of their insulin resistance.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).